Why my doctor and I chose VYVGART for IV infusion

Sue was diagnosed with anti-AChR antibody positive gMG in 2021 and started on VYVGART for intravenous (IV) infusion in 2022. In this guest post, she shares how her diagnosis and treatment journey led her to VYVGART for IV infusion, and why it’s been the right choice for her.

Sue
Started on VYVGART for IV infusion in 2022

Sue is a paid spokesperson of argenx.

I was in my car at a red light when the double vision hit. Nothing could have prepared me for the shock and terror of being behind the wheel of a car and realizing that I couldn’t rely on my eyes. I knew right away that I needed help, and I was willing to try anything.

I’m no stranger to working through challenges in my life. I was a military wife for 17 years before my first husband and I separated. When that happened, I knew it was up to me to support my family, so I worked my way up from a secretary in the government to a mechanical engineering technician. I eventually remarried, and my second husband and I did everything together. He was my best friend, and my work made me happy and confident in ways I hadn’t felt before. But when he passed away suddenly in 2015, I really struggled to find purpose in my life without him. Eventually, I found that purpose in an unexpected way: working with other grieving families in my community who are going through a loss like the one I experienced.

So when the double vision started, I knew it was another challenge to face head-on. Unfortunately, the symptoms in my eyes progressed to the rest of my body. I had muscle fatigue, a weakened voice, and general fatigue. I had to stop doing many of the things I loved, like sewing, watching TV, reading, and attending events and activities with my friends and family. I was couch-ridden. I was sad. I felt like I had lost my purpose again.

My primary care doctor ran a bunch of blood tests, including an antibody test, and diagnosed me with anti-AChR antibody positive gMG. My symptoms were still severe, but I felt a sense of relief because I knew what was causing them and I could take action. I was ready to try anything to reduce my symptoms. She referred me to a general neurologist who prescribed me a few medications. The first medication he prescribed didn’t help me, and the side effects actually made me feel much worse. The next medication he prescribed me didn’t have bad side effects, but I didn’t feel any symptom improvement. At that point, the relief I felt from being diagnosed was gone, and I was starting to feel hopeless.


“My neurologist and I both decided it was worth it to try an additional treatment”


I was referred to a neurologist who is a gMG specialist, and he shared the same feelings I had about how bad my symptoms had become. I was extremely weak and had to walk using a cane. That was on top of my gMG symptoms that were already making it difficult to live my life. We talked over the effects of the previous medications and what my options were for other treatments. By the end of that discussion, my neurologist and I both decided it was worth it to try an additional treatment.

That’s when he recommended VYVGART for IV infusion. I was a little apprehensive of starting an additional treatment that wouldn’t give me the results I wanted, but I decided the risk was worth it once we took the time to weigh the potential benefits and side effects. He told me the most common side effects are respiratory tract infection, headache, and urinary tract infection.

Talk to your neurologist to see if VYVGART for IV infusion is right for you

I’ve been on VYVGART for IV infusion for 2 and a half years. After the first treatment cycle, my muscle fatigue lessened, and my voice got stronger. By the second cycle, I was able to start doing things I hadn’t been able to do for a while, like cooking for myself, making the bed, taking out the trash, and reading. And after the third cycle, I was able to make plans to go out and spend meaningful time with my family and friends again. Even though I’m still not able to sew, I’m teaching 2 of my granddaughters to sew, and I really treasure spending this time with them.

Sue Sue Sue
Sue Sue Sue

Tracking my symptoms during my treatment journey has helped me. The Myasthenia Gravis Activities of Daily Living (MG-ADL) scale assesses the impact of gMG on daily functions by measuring 8 signs or symptoms that are commonly affected in gMG. I use it to see when my score starts to rise, so I know when it’s time to talk to my doctor about starting my next treatment cycle.* I also track them during my cycle, because if I see the numbers go down, it gives my confidence a boost.

Use the MG-ADL scale to help track your symptoms

I’ve been through a lot in my life, but I always find a way to do whatever it takes to improve my circumstances. I weighed my options with VYVGART for IV infusion, and it has worked out for me. I encourage others in the gMG community to remember that you are your own best judge of how you feel. It’s okay to say, “I’m not doing as well as I want to, and I need to talk to my doctor about trying an additional treament.”

AChR=acetylcholine receptor.
*The safety of starting the next treatment cycle sooner than 4 weeks from the last treatment of the previous treatment cycle has not been established.

VYVGART Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) | VYVGART (efgartigimod alfa-fcab)
VYVGART Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) | VYVGART (efgartigimod alfa-fcab)

Still have questions? Call 1-833-VYVGART (1-833-898-4278) to speak with an educator about gMG, how VYVGART works in the body, study data, cost and coverage, and more.

Do not take VYVGART if you are allergic to efgartigimod alfa or any of the ingredients in VYVGART. Do not take VYVGART HYTRULO if you are allergic to efgartigimod alfa, hyaluronidase, or any of the ingredients in VYVGART HYTRULO. VYVGART or VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.

Before taking VYVGART or VYVGART HYTRULO, tell your healthcare provider about all of your medical conditions, including if you:

  • have an infection or fever.
  • have recently received or are scheduled to receive any vaccinations.
  • have any history of allergic reactions.
  • have kidney (renal) problems.
  • are pregnant or plan to become pregnant. It is not known whether VYVGART or VYVGART HYTRULO will harm your unborn baby.
    • Pregnancy Exposure Registry. There is a pregnancy exposure registry for women who use VYVGART or VYVGART HYTRULO during pregnancy. The purpose of this registry is to collect information about your health and your baby. Your healthcare provider can enroll you in this registry. You may also enroll yourself or get more information about the registry by calling 1-855-272-6524 or going to VYVGARTPregnancy.com
  • are breastfeeding or plan to breastfeed. It is not known if VYVGART or VYVGART HYTRULO passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

VYVGART or VYVGART HYTRULO can cause side effects which can be serious, including:

  • Infection. VYVGART or VYVGART HYTRULO may increase the risk of infection. If you have an active infection, your healthcare provider should delay your treatment with VYVGART or VYVGART HYTRULO until your infection is gone. Tell your healthcare provider right away if you get any of the following signs and symptoms of an infection:
    • fever
    • chills
    • frequent and painful urination
    • cough
    • pain and blockage of nasal passages
    • wheezing
    • shortness of breath
    • sore throat
    • excess phlegm
    • nasal discharge
  • Allergic reactions (hypersensitivity reactions). VYVGART or VYVGART HYTRULO can cause allergic reactions that can be severe. These reactions can happen during, shortly after, or weeks after your VYVGART infusion or VYVGART HYTRULO injection. Tell your healthcare provider or get emergency help right away if you have any of the following symptoms of an allergic reaction with VYVGART or VYVGART HYTRULO:
    • rash
    • swelling of the face, lips, throat, or tongue
    • shortness of breath
    • trouble breathing
    • low blood pressure
    • fainting

An additional symptom of an allergic reaction with VYVGART HYTRULO can include hives.

  • Infusion or injection-related reactions. VYVGART can cause infusion-related reactions. VYVGART HYTRULO can cause infusion or injection-related reactions. These reactions can happen during or shortly after your VYVGART infusion or VYVGART HYTRULO injection. Tell your healthcare provider if you have any of the following symptoms of an infusion or injection-related reaction:
    • high blood pressure
    • chills
    • shivering
    • chest, stomach, or back pain

The most common side effects of VYVGART or VYVGART HYTRULO include respiratory tract infection, headache, and urinary tract infection. An additional common side effect with VYVGART HYTRULO includes injection site reactions.

These are not all the possible side effects of VYVGART or VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is VYVGART® (efgartigimod alfa-fcab) for intravenous (IV) infusion and what is VYVGART HYTRULO® (efgartigimod alfa and hyaluronidase-qvfc) for subcutaneous injection?

VYVGART and VYVGART HYTRULO are both prescription medicines used to treat adults with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive.

It is not known if VYVGART or VYVGART HYTRULO is safe and effective in children.

Please see full Prescribing and Patient Information for VYVGART HYTRULO for subcutaneous injection and full Prescribing Information for VYVGART for IV infusion.

Dosage forms and strengths:

VYVGART Hytrulo is available as a single-dose subcutaneous injection containing: 200 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per prefilled syringe, or 180 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per vial. VYVGART is available as a single-dose injection for intravenous use containing 400 mg/20 mL of efgartigimod alfa-fcab per vial.

Do not take VYVGART if you are allergic to efgartigimod alfa or any of the ingredients in VYVGART. Do not take VYVGART HYTRULO if you are allergic to efgartigimod alfa, hyaluronidase, or any of the ingredients in VYVGART HYTRULO. VYVGART or VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.

Before taking VYVGART or VYVGART HYTRULO, tell your healthcare provider about all of your medical conditions, including if you:

  • have an infection or fever.
  • have recently received or are scheduled to receive any vaccinations.
  • have any history of allergic reactions.
  • have kidney (renal) problems.
  • are pregnant or plan to become pregnant. It is not known whether VYVGART or VYVGART HYTRULO will harm your unborn baby.
    • Pregnancy Exposure Registry. There is a pregnancy exposure registry for women who use VYVGART or VYVGART HYTRULO during pregnancy. The purpose of this registry is to collect information about your health and your baby. Your healthcare provider can enroll you in this registry. You may also enroll yourself or get more information about the registry by calling 1-855-272-6524 or going to VYVGARTPregnancy.com
  • are breastfeeding or plan to breastfeed. It is not known if VYVGART or VYVGART HYTRULO passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

VYVGART or VYVGART HYTRULO can cause side effects which can be serious, including:

  • Infection. VYVGART or VYVGART HYTRULO may increase the risk of infection. If you have an active infection, your healthcare provider should delay your treatment with VYVGART or VYVGART HYTRULO until your infection is gone. Tell your healthcare provider right away if you get any of the following signs and symptoms of an infection:
    • fever
    • chills
    • frequent and painful urination
    • cough
    • pain and blockage of nasal passages
    • wheezing
    • shortness of breath
    • sore throat
    • excess phlegm
    • nasal discharge
  • Allergic reactions (hypersensitivity reactions). VYVGART or VYVGART HYTRULO can cause allergic reactions that can be severe. These reactions can happen during, shortly after, or weeks after your VYVGART infusion or VYVGART HYTRULO injection. Tell your healthcare provider or get emergency help right away if you have any of the following symptoms of an allergic reaction with VYVGART or VYVGART HYTRULO:
    • rash
    • swelling of the face, lips, throat, or tongue
    • shortness of breath
    • trouble breathing
    • low blood pressure
    • fainting

An additional symptom of an allergic reaction with VYVGART HYTRULO can include hives.

  • Infusion or injection-related reactions. VYVGART can cause infusion-related reactions. VYVGART HYTRULO can cause infusion or injection-related reactions. These reactions can happen during or shortly after your VYVGART infusion or VYVGART HYTRULO injection. Tell your healthcare provider if you have any of the following symptoms of an infusion or injection-related reaction:
    • high blood pressure
    • chills
    • shivering
    • chest, stomach, or back pain

The most common side effects of VYVGART or VYVGART HYTRULO include respiratory tract infection, headache, and urinary tract infection. An additional common side effect with VYVGART HYTRULO includes injection site reactions.

These are not all the possible side effects of VYVGART or VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is VYVGART® (efgartigimod alfa-fcab) for intravenous (IV) infusion and what is VYVGART HYTRULO® (efgartigimod alfa and hyaluronidase-qvfc) for subcutaneous injection?

VYVGART and VYVGART HYTRULO are both prescription medicines used to treat adults with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive.

It is not known if VYVGART or VYVGART HYTRULO is safe and effective in children.

Please see full Prescribing and Patient Information for VYVGART HYTRULO for subcutaneous injection and full Prescribing Information for VYVGART for IV infusion.

Dosage forms and strengths:

VYVGART Hytrulo is available as a single-dose subcutaneous injection containing: 200 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per prefilled syringe, or 180 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per vial. VYVGART is available as a single-dose injection for intravenous use containing 400 mg/20 mL of efgartigimod alfa-fcab per vial.